The company has two Phase 3 data releases for Paltusotine in treating acromegaly over the next 7-8 months. Acromegaly is a disorder caused by excess levels of growth hormone, and current ...

Although the medical condition acromegaly may be fairly rare, for those who do live with the hormone disorder, it can cause a ...

Acromegaly is a serious endocrine disease associated with increased mortality and comorbidity. 1 The main therapeutic goal in patients with acromegaly is, therefore, to eliminate (progression of ...

For informational purposes only. Consult a medical professional for advice. Source: Focus Medica. A rare condition which results from excessive production of growth hormone by the pituitary gland ...

He's a great guy, and it's unfortunate that he didn't live very long. It's sad that he had that [acromegaly] disease.

Crinetics just released initial data from its phase 2 open-label study using its drug Atumelnant. Read why I'm bullish on ...

Keep abreast with the latest news related to Acromegaly there are 48 news items on Acromegaly that covers updates, breakthroughs and in-depth reports. We provide you with a free downloadable ...

Are you searching for medications to treat 'Acromegaly'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Acromegaly. The page includes both ...

The drugmaker said its product is indicated for the treatment of patients with acromegaly and gastroenteropancreatic ...

Your endocrinologist may help manage your cholesterol levels if you have a hormone condition, such as growth hormone deficiency, diabetes, acromegaly, hypothyroidism, hyperthyroidism, or Cushing's ...

Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions ...